House rules
This article was originally published in The Tan Sheet
Executive Summary
"It is insupportable that in some cases FDA has given information about major policy matters to the press before providing the same information to Congress," according to a House conference report accompanying the omnibus spending bill. The report stresses the agency should advise the committees of any changes regarding drug safety. Report language stems from FDA's handling of safety concerns regarding Vioxx and antidepressants...